Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques

Bone Marrow Transplantation

Volumn 22, Issue 8, 1998, Pages 771-775

  Hildebrandt, M O ^a,b   Blaser F ^a   Beyer, J ^a   Siegert, W ^a   Mapara, M Y ^b   Huhn, D ^a   Salama, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Alkaline phosphatase; Germ cell tumors; Peripheral blood; RT PCR

Indexed keywords

ALKALINE PHOSPHATASE; CELL ENZYME; CISPLATIN; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; PACLITAXEL;

APHERESIS; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; GERM CELL TUMOR; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION; TESTIS CANCER; TUMOR CELL;

EID: 0031736564     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701416     Document Type: Article

References (23)

1. Bosl GJ, Motzer RJ. Medical progress: testicular germ-cell cancer. New Engl J Med 1997; 337: 242-253.
2. Bajorin D, Katz A, Chan E et al. Comparison of criteria for assigning germ cell tumor patients to 'good risk' and 'poor risk' studies. J Clin Oncol 1988; 6: 786-792.
3. Beyer J, Bokemeyer C, Schmoll HJ, Siegert W. Treatment intensification in disseminated germ-cell tumors. World J Urol 1994; 12: 207-213.
4. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 1993; 341: 1134-1137.
5. Gribben JG, Arnold MD, Freedman MD et al. Immunologic purging of marrow assessed before autologous bone marrow transplantation for B cell lymphoma, New Engl J Med 1991; 325: 1525-1533.
6. Lin F, Cross NCP. Molecular methods for monitoring malignant disease after bone marrow transplantation. Curr Opin Oncol 1995; 2: 460-467.
7. Ross AA, Cooper BW, Lazarus HM et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993; 82: 2605-2610.
8. Shpall EJ, Jones RB. Release of tumor cells from bone marrow. Blood 1994; 83: 623-625.
9. Miettinen M, Virtanen I, Talerman A. Intermediate filament proteins in human testis and testicular germ-cell tumors. Am J Pathol 1985; 120: 402-410.
10. Mapara MY, Körner IJ, Hildebrandt M et al. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 1997; 89: 337-344.
11. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 1987; 56: 881-914.
12. Siegert W, Beyer J, Strohscheer I et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. J Clin Oncol 1994; 12: 1223-1231.
13. Mead GM. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15: 594-603.
14. Chomczynski P, Sacchi N, Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
15. Bouaboula M, Legoux P, Pességué B et al. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem 1992; 267: 21830-21838.
16. Millan JL, Manes T. Seminoma-derived Nagao isozyme is encoded by a germ-cell alkaline phosphatase gene. Proc Natl Acad Sci USA 1988; 85: 3024-3028.
17. Hildebrandt M, Mapara MY, Körner IJ et al. Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency. Exp Hematol 1997; 25: 57-65.
18. Giwercman A, Cantell L, Marks A. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F. Acta Pathol Microbiol Immunol Scand 1991; 99: 586-594.
19. Goldstein DJ, Rogers C, Harris H. A search for trace expression of placental-like alkaline phosphatase in nonmalignant human tissues: demonstration of its occurrence in lung, cervix, testis and thymus. Clin Chim Acta 1982; 125: 63-75.
20. Harmenberg U, Koha M, Makiya R et al. Identification and characterization of alkaline phosphatase isozymes in human colorectal adenocarcinomas. Tumour Biol 1991; 12: 237-248.
21. Iles RK, Ind TE, Chard T. Production of placental alkaline phosphatase (PLAP) and PLAP-like material by epithelial germ cell and non-germ cell tumours in vitro. Br J Cancer 1994; 69: 274-278.
22. al-Mudamgha ZA, Rassam MB, al-Salihi AR, al-Sammeraie FT. Alkaline phosphatase of cancerous larynx tissue in comparison with the placental enzyme. Biochemical and histochemical studies. Acta Oncol 1997; 36: 213-218.
23. Schär BK, Otto VI, Hanseler E, Simultaneous detection of all four alkaline phosphatase isoenzymes in human germ cell tumors using reverse transcrition-PCR, Cancer Res 1997; 57: 3841-3846.